Schedule 13G ownership disclosure

Cancer Genetics Inc

Security class unavailable · CUSIP: 13739U203

Event date: 2021-02-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
710,905
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-21-007591
Form type
SC 13G
Filer
Vyant Bio, Inc.
CIK
CIK 1349929
Filed
Feb 09, 2021
Reporting period
Feb 01, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub